Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) vs Translational Development Acquisition Corp. (TDAC)
A side-by-side comparison of Drugs Made In America Acquisition Corp. Ordinary Shares and Translational Development Acquisition Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DMAA
Drugs Made In America Acquisition Corp. Ordinary Shares
$10.84Financial ServicesDelayed quote: Oct 6, 2026, 1:39 PM EDT
TDAC
Translational Development Acquisition Corp.
$10.83Financial ServicesDelayed quote: Oct 6, 2026, 1:34 PM EDT
Total return — DMAA vs TDAC
growth of $100 · dividends reinvested · last 2yDMAA +9.3% (+4.6%/yr)TDAC +8.1% (+4.0%/yr)DMAA compounded faster over this window
DMAA TDAC
DMAA vs TDAC: by the numbers
- •TDAC is the larger company ($267M vs $263M market cap).
- •TDAC trades at the lower trailing earnings multiple (42.06 vs 55.22 P/E), one valuation lens rather than an overall verdict.
Metrics side by side
Valuation
| Metric | DMAA | TDAC |
|---|---|---|
| P/E ratio | 55.22 | 42.06 |
| P/B ratio | 1.91 | 1.78 |
Profitability
| Metric | DMAA | TDAC |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | 4.42% | 3.70% |
| ROIC | -1.82% | -0.84% |
Frequently asked
- Which has the lower trailing P/E, DMAA or TDAC?
- TDAC has the lower trailing P/E: DMAA trades at 55.22 and TDAC at 42.06. P/E is one valuation measure and does not by itself establish which business is cheaper.
Go deeper
Dig into the metrics
Drugs Made In America Acquisition Corp. Ordinary Shares P/E ratioTranslational Development Acquisition P/E ratioDrugs Made In America Acquisition Corp. Ordinary Shares ROETranslational Development Acquisition ROEDrugs Made In America Acquisition Corp. Ordinary Shares operating marginTranslational Development Acquisition operating marginDrugs Made In America Acquisition Corp. Ordinary Shares revenue growthTranslational Development Acquisition revenue growthDrugs Made In America Acquisition Corp. Ordinary Shares free cash flowTranslational Development Acquisition free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.